Business
Currency:USD
2023/FY
Stock NameRevenueRatio
Business of developing and commercializing novel therapies for fibrotic diseases1.58M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States of America1.58M100.00%